홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

Water → 1-[3-(4-Chloro-phenyl)-[1,2,4]thiadiazol-5-yl]-4-[2-(4-methoxy-phenyl)-allyl]-piperazine

HRID 570569
인쇄

반응식

HRID 570569 반응식
[Br-].[CH3:2][P+](C1C=CC=CC=1)(C1C=CC=CC=1)C1C=CC=CC=1.[NH2-].[Na+].[Cl:24][C:25]1[CH:30]=[CH:29][C:28]([C:31]2[N:35]=[C:34]([N:36]3[CH2:41][CH2:40][N:39]([CH2:42][C:43]([C:45]4[CH:50]=[CH:49][C:48]([O:51][CH3:52])=[CH:47][CH:46]=4)=O)[CH2:38][CH2:37]3)[S:33][N:32]=2)=[CH:27][CH:26]=1.O.CCOC(C)=O>C1COCC1>[Cl:24][C:25]1[CH:26]=[CH:27][C:28]([C:31]2[N:35]=[C:34]([N:36]3[CH2:41][CH2:40][N:39]([CH2:42][C:43]([C:45]4[CH:46]=[CH:47][C:48]([O:51][CH3:52])=[CH:49][CH:50]=4)=[CH2:2])[CH2:38][CH2:37]3)[S:33][N:32]=2)=[CH:29][CH:30]=1
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

6

반응물 4

HCID 962WaterHCID 8857Ethyl AcetateHCID 16212304Sodium;azanide;methyl(triphenyl)phosphanium;bromideHCID 711862252-(4-(3-(4-Chlorophenyl)-1,2,4-thiadiazol-5-yl)piperazin-1-yl)-1-(4-methoxyphenyl)ethanone

생성물 1

HCID 715033301-[3-(4-Chloro-phenyl)-[1,2,4]thiadiazol-5-yl]-4-[2-(4-methoxy-phenyl)-allyl]-piperazine

시약·촉매·용매 1

HCID 8028Tetrahydrofuran용매2회

실험 절차

A mixture of methyltriphenylphosphonium bromide/sodium amide (57.7 mg, 146 μmol) was combined with THF (5 mL) to give a yellow suspension and stirred for 1 h at RT. 2-(4-(3-(4-chlorophenyl)-1,2,4-thiadiazol-5-yl)piperazin-1-yl)-1-(4-methoxyphenyl)ethanone (50 mg, 117 μmol) dissolved in THF (3 mL) was added drop-wise via syringe over 5 min. The resulting orange suspension was stirred over night at RT. Water (10 mL) and EtOAc (10 mL) was added and stirred for 10 min. The aqueous layer was separated and extracted with EtOAc (1×10 mL). The organic layers were washed with brine (1×10 mL), dried over Na2SO4, filtered off and concentrated in vacuo. The residue was purified by column chromatography on silica eluting with a gradient formed from heptane and EtOAc to yield, after evaporation of the product containing fraction, 33 mg (66%) of the title compound as off-white solid. MS (m/e): 427.2 (MH+).

후처리

  1. customto give a yellow suspension
  2. additionwas added drop-wise via syringe over 5 min
  3. stirringThe resulting orange suspension was stirred over night at RT
  4. stirringstirred for 10 min
  5. customThe aqueous layer was separated
  6. extractionextracted with EtOAc (1×10 mL)
  7. washThe organic layers were washed with brine (1×10 mL)
  8. dry with materialdried over Na2SO4
  9. filtrationfiltered off
  10. concentrationconcentrated in vacuo
  11. customThe residue was purified by column chromatography on silica eluting with a gradient
  12. customformed from heptane and EtOAc
  13. customto yield
  14. customafter evaporation of the product
  15. additioncontaining fraction, 33 mg (66%) of the title compound as off-white solid

출처 및 근거

ORD 기록
ord-b37171b11e6b4a79a9c0c57e6227a791
출처 데이터셋
uspto-grants-2015_05
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US09023852B2

반응 노트

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트